INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 25 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | +18.2% | 14,493 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -72.5% | 14,493 | -46.3% | 0.00% | – |
| Q1 2022 | $40,000 | +122.2% | 26,986 | +116.0% | 0.00% | -100.0% |
| Q4 2021 | $18,000 | -63.3% | 12,494 | -51.9% | 0.00% | -62.5% |
| Q3 2021 | $49,000 | -80.6% | 26,000 | -71.1% | 0.01% | -83.7% |
| Q2 2021 | $252,000 | – | 90,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 1,076,500 | $1,593,000 | 1.68% |
| Lynwood Capital Management Inc. | 120,000 | $178,000 | 0.19% |
| Retirement Planning Co of New England, Inc. | 116,402 | $172,000 | 0.10% |
| Kepos Capital LP | 700,000 | $1,036,000 | 0.08% |
| HAMILTON LANE ADVISORS LLC | 165,635 | $245,000 | 0.06% |
| Redmond Asset Management, LLC | 122,682 | $182,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 99,000 | $147,000 | 0.02% |
| Antara Capital LP | 303,000 | $448,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 93,800 | $139,000 | 0.01% |
| Shay Capital LLC | 20,000 | $30,000 | 0.00% |